Since astrocytes are the main controller of Cu homeostasis in the brain, abnormal non-Cp Cu levels may be associated with FABP7+ astrocytes in a disease-associated metabolic sub-pathway, eventually leading to AD. Here, FABP7 is linked to Alzheimer disease.